‘Antisense’ drug expected to change — and save — lives
CHICAGO, December 23, 2016— The Muscular Dystrophy Association today celebrated news of the U.S. Food and Drug Administration’s decision to grant approval for nusinersen (brand name Spinraza), the first disease-modifying drug to treat the most common genetic cause of death in infants.
CHICAGO, Dec. 1, 2016 – After a comprehensive, nationwide search, MDA is pleased to announce the appointment of Karen Lewis Alexander as its new Executive Vice President and Chief Revenue Officer. Alexander will join MDA in this newly created leadership role as a member of its Executive Staff Team beginning Tuesday, January 17.
CHICAGO, Dec.1, 2016 - In response to the passing of legendary broadcast executive Robert M. Bennett, former president, chairman and emeritus member of the Muscular Dystrophy Association Board of Directors, the extended MDA family today mourns his loss. Bob was 89 and lived in Newport Beach, California, with his wife of 66 years Marjie.